US workshop aims to boost paediatric cardio device development
This article was originally published in RAJ Devices
The US Food and Drug Administration is planning to hold on 30 September a public workshop to identify clinical trial designs that lend themselves to overcoming the challenges in developing cardiovascular devices for paediatrics1.
You may also be interested in...
Five new drugs have been recommended for EU approval at the latest meeting of European Medicines Agency’s drug evaluation committee.
The European Commission has set aside, for now, concerns expressed by member states regarding the scope of medicines subjected to additional monitoring requirements.
A new work sharing pilot has been launched to evaluate jointly generic drugs intended for launch in Singapore and Malaysia.